Repligen Corp. (RGEN)

114.82 -2.13 (-1.82%) USD  |  NASDAQ  |  Apr 07, 12:43
More

Repligen Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Masimo Corp. Upgrade
Orthofix Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
Plus Therapeutics, Inc. --